Pediatric renovascular hypertension

T G Wells1, C W Belsha

  • 1Arkansas Children's Hospital, Little Rock 72202, USA.

Insights

Renovascular hypertension in children can cause serious health issues. Early diagnosis and tailored treatments like angioplasty or surgery are key to managing this condition and preserving kidney function.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Disease
  • Diagnostic Imaging

Background:

  • Renovascular disease is a significant cause of severe hypertension in pediatric patients.
  • It can lead to severe morbidity, including neurologic injury and congestive heart failure, often with subtle presenting symptoms.

Purpose of the Study:

  • To review the diagnostic and therapeutic strategies for renovascular hypertension in children.
  • To emphasize an individualized approach to treatment based on lesion characteristics and patient factors.

Main Methods:

  • Review of current radiographic techniques for detecting renovascular lesions, comparing them to intra-arterial digital subtraction angiography.
  • Discussion of diagnostic adjuncts such as renal venous renin sampling, duplex ultrasonography, and captopril-enhanced renal scintigraphy.
  • Overview of therapeutic options including percutaneous transluminal angioplasty, surgical correction, pharmacologic therapy, and nephrectomy.

Main Results:

  • No single radiographic technique has consistently outperformed intra-arterial digital subtraction angiography for lesion detection.
  • Percutaneous transluminal angioplasty is often the preferred treatment for specific lesions like renal transplant artery stenosis and fibromuscular dysplasia.
  • Surgical correction is effective for more extensive lesions, while pharmacologic therapy is reserved for non-responders or unreconstructable cases.

Conclusions:

  • An individualized therapeutic approach is crucial for managing pediatric renovascular hypertension.
  • Treatment aims to cure hypertension and preserve or restore renal function.
  • Management strategies must consider the specific nature and extent of the renovascular disease.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...